Barclays »

Cellectar Biosciences shares owned by Barclays

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 338k 3.98

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Cellectar Biosciences

AIGH Capital Management
Nantahala Capital Management
Vanguard Group
ADAR1 Capital Management
Rosalind Advisors
Barclays
Geode Capital Management
Citadel Advisors
Hudson Bay Capital Management
BlackRock
Lighthouse Investment Partners
Jane Street
Northern Trust
Susquehanna International
Goss Wealth Management

View all funds holding Cellectar Biosciences